Healthcare

This Drug Discovery TechVision Opportunity Engine (TOE) provides insights across research advances in gene editing technologies that have enabled enhanced drug screening and target discovery. Furthermore, the service also includes regulatory advances for 3,4-methlyenedioxymethamaphetamine and Ibrutinib therapies. Interestingly, the TOE encompasses...

This edition of the Genetic Technology TOE depicts trends across targeted therapies. Few important targeted therapy innovations have been presented along with summary of clinical trials for CAR T 19 and CTL019 therapies. The focus of the TOE is on disease screening and management. The corresponding clinical trials scenario is also depicted along...

This edition of the Genetic Technology TOE depicts trends across cancer immunotherapy. Different innovations and collaborations among the main participants in the field are illustrated. The corresponding clinical trials scenario is depicted, along with the industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents t...

This edition of the Genetic Technology TOE depicts trends across T cell-based therapeutics. Novel T cell receptor-based therapeutic platforms and robust T cell target discovery platforms are profiled. The corresponding clinical trials scenario is also depicted, along with industry interactions. The Genetic Technology TechVision Opportunity Engine ...

The latest issue of Medical and Diagnostic Imaging Technologies (MDIT) TechVision Opportunity Engine (TOE) profiles innovations in medical and diagnostic imaging. The profiles covered include quantitative tissue assessment using ultrasound, an artificial intelligence-based skin cancer diagnostic tool, an ophthalmic imaging tool for corneal epitheli...

This edition of the Genetic Technology TOE depicts trends across genetic technologies enabling enhanced insights across disease pathogenesis and management. The corresponding clinical validation scenario is depicted along with the industry interactions. A summary of active and completed clinical studies for VM202, a novel gene therapy candidate fo...

This edition of Future Tech TechVision Opportunity Engine (TOE) covers the impact of wearable technology on the pharmaceutical industry. Wearables are wireless, sensor integrated devices worn on the body, which can accurately measure body physiological functions and alert users when abnormal parameter levels or fluctuations occur. All these attribu...

The latest edition of the Drug Discovery TOE profiles emerging technology platforms, strategic business models and initiatives, breakthrough approvals and trials for drug discovery and development. The role and impact of emerging technology such as artificial intelligence in drug discovery has also been discussed. This TOE issue profiles innovation...

This edition of the Genetic Technology TOE depicts trends across bio-therapies. Monoclonal antibody therapies and siRNA therapies, constitute some examples of the profiled technologies, companies, and university. The corresponding clinical trial scenario is depicted, along with the industry interactions. The Genetic Technology TechVision Opportuni...